Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,181 | -16,291 | -9,417 | 17,859 | -21,796 |
| Depreciation Amortization | 371 | 227 | 111 | 418 | 311 |
| Accounts receivable | 50,754 | 50,926 | 49,392 | -20,885 | 29,675 |
| Accounts payable and accrued liabilities | -824 | -378 | -951 | 729 | 682 |
| Other Working Capital | 51,300 | 60,669 | 48,079 | -22,290 | 13,664 |
| Other Operating Activity | -42,675 | -45,861 | -46,266 | 29,047 | -23,453 |
| Operating Cash Flow | $31,745 | $49,292 | $40,948 | $4,878 | $-917 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -755 | -631 | -32 | -723 | -376 |
| Purchase Of Investment | -173,739 | -99,762 | -77,941 | -133,845 | -104,201 |
| Sale Of Investment | 108,050 | 62,450 | 26,900 | 150,170 | 109,050 |
| Investing Cash Flow | $-66,444 | $-37,943 | $-51,073 | $15,602 | $4,473 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,975 | 9,975 | N/A | 4,676 | N/A |
| Common Stock Issued | 9,291 | 7,881 | 1,128 | 3,269 | 2,678 |
| Other Financing Activity | -473 | -473 | -473 | -429 | -297 |
| Financing Cash Flow | $18,793 | $17,383 | $655 | $7,516 | $2,381 |
| Beginning Cash Position | 40,020 | 40,020 | 40,020 | 12,024 | 12,024 |
| End Cash Position | 24,114 | 68,752 | 30,550 | 40,020 | 17,961 |
| Net Cash Flow | $-15,906 | $28,732 | $-9,470 | $27,996 | $5,937 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,745 | 49,292 | 40,948 | 4,878 | -917 |
| Capital Expenditure | -755 | -631 | -32 | -723 | -376 |
| Free Cash Flow | 30,990 | 48,661 | 40,916 | 4,155 | -1,293 |